New Ouchless® Needle Collection Announces Leading Dermatology Testimonial
FDA-compliant devices revolutionize cosmetic injectables treatments with state-of-the-art pain reducing technology.
LOUISVILLE, Ky., Jan. 23, 2012 /PRNewswire/ -- Ouchless® Needle by BellaNovus Development Company LLC, a medical design and manufacturing company, announces that Dr. Mariano Busso is the latest in a growing list of physicians nationwide to announce the adoption of its use for cosmetic injections. Dr. Busso is on the forefront of this innovative, emerging technology that minimizes localized pain resulting from cosmetic injections. Ouchless® Needle is a disposable syringe-attachable dispenser that delivers an instant topical refrigerant to the skin just prior to needle insertion.
(Photo: http://photos.prnewswire.com/prnh/20120123/CL39966 )
The popularity of neurotoxin and soft tissue filler injection procedures rose nearly 400% during the past decade, according to the American Society of Plastic Surgeons. The Ouchless® Needle eliminates waiting time, works to instantly reduce the pain associated with an injection, minimizes post-injection numbness, swelling and bruising, and provides patients a far superior injectable treatment experience. While numbing creams can take up to 40 minutes to work and may cause face discoloration, the Ouchless® Needle delivers a short spray of FDA-compliant blend of vapocoolant onto the skin before the skin is pierced. The vapocoolant spray immediately refrigerates the skin, reducing the feeling of needle penetration and making the injection more comfortable. The Ouchless® Needle Collection is available in models to work with most commonly used cosmetic injection syringes.
Dr. Busso is board certified by the American Board of Dermatology and his practice is in Coconut Grove, Florida. He is an accomplished doctor, being a Fellow of the American Academy of Dermatology and a member of the American Society of Dermatologic Surgery. Dr. Busso is the only physician in the US that has performed clinical trials for Radiesse® and Artefill®, and is a clinical trainer for Restylane® and BOTOX® and has participated on the advisory board for Sculptra®.
"The Ouchless® Needle is great because it makes cosmetic procedures available to anyone, regardless of their pain tolerance," said Dr. Busso. "As a cosmetic physician, I have seen far too many patients struggle with the pain of cosmetic injectables and in many cases this fear of pain leads patients to not have cosmetic procedures at all. That is why I use this groundbreaking tool to help make these procedures less painful and revolutionize the way patients receive injectable treatments."
The models are available in boxes of fifteen devices ($285 or less) or in sample boxes of four ($82 or less). Ouchless® Needle is available only to clinicians and licensed injectors online at www.ouchlessneedle.com or by calling 1.800.730.3015, and through distributors in select US markets.
Photos and video available at www.ouchlessneedle.com.
Botox® is a registered trademark of Allergan, Inc. Restylane® is a registered trademark of HA North American Sales AB Corporation Sweden. Sculptra® is a registered trademark of Aventis (Ireland) LLC. Radiesse® is a registered trademark of Merz Aesthetics, Inc. Artefill® is a registered trademark of Artes Medical USA, Inc.
SOURCE BellaNovus Development Company LLC
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article